Replies to post #208789 on Elite Pharmaceuticals Inc (ELTP)

[Couch]

The FDA is moving toward phasing in ADT opioids and they say possibility phasing out generic ADTs.

Nobody is following the mob mentality just the opposite. Slow and steady wins the race.

http://www.drugfree.org/join-together/commentary-abuse-deterrent-opioids-needs-cost/

Clearly, if we want to encourage wide-spread adoption of ADF opioid pain relievers (and I think we certainly do), we need to take the necessary steps to make them affordable. That is why many pain management advocates support legislation that requires the use of ADFs in most instances, but only when coupled with a provision that third-party payers (insurance companies, Medicare, Medicaid, etc.) cover them so that patients’ out-of-pocket cost is as low as possible. Massachusetts did just that in a law it passed last year, and we at the Academy are advocating for similar provisions in bills that are now popping up in many state legislatures.